Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Get Alerts

Divi's Laboratories Ltd

NSE: DIVISLAB · BSE: 532488 · Pharmaceuticals & Biotechnology · 21 announcements

Share price
₹9,550.00
Market cap
₹2,53,523 Cr
Revenue (annual)
₹10,560 Cr
Net profit (annual)
₹2,568 Cr
P/E (TTM)
86.7×Sector 47.4×
Promoter holding
51.88%+0.00% QoQ
FII holding
20.38%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 5Financial Results 3Promoter Selling 2Earnings Call 2Board Meeting Date 2Annual General Meeting 2Management Change 1Dividend 1Capital Structure Change 1Business Update 1Annual Report 1

Time

All time Last 1 weekLast 1 monthLast 2 monthsLast 3 monthsLast 6 monthsLast 1 year

3 announcements with these filters

11:34 IST NSE
Financial Results

Divi's Laboratories Q1 FY27 Results: Net Profit ₹902 Cr, Up 65.5% YoY

Divi's Laboratories Ltd reported revenue from operations of ₹3,080 Cr (+27.8% YoY) and net profit of ₹902 Cr (+65.5% YoY) for Q1 FY27.

Key figure
Net profit ₹902 Cr · +65.5% YoY
Open full results → Read the filing ↗
12:12 IST BSE
Financial Results

Divi's Laboratories Financial Results

Divis Laboratories reported a consolidated annual net profit of ₹2,568 Crore. The board also recommended a final dividend of ₹30 per equity share.

Value
₹2,568 Cr
Read the filing ↗